Some containers were found to have an "offensive" odor that has been associated with gastrointestinal symptoms.

The announcement came from McNeil Consumer Healthcare, one of Johnson & Johnson's companies. McNeil says in a news release that the product was manufactured in February 2009, and that it was recalling the pills following a "small number" of reports of a musty, moldy odor.

McNeil said the odor has been linked to the presence of trace amounts of a chemical known as 2,4,6-tribromoanisole (TBA), which is a by-product of a chemical preservative sometimes used on shipping pallets. The company said it was taking the action as a precaution and that the risk of serious adverse medical events is "remote."

Each recalled bottle contains 225 caplets. In addition to causing unusual, unpleasant odors, TBA has been associated with temporary and non-serious gastrointestinal symptoms.

In March 2011, the McNeil division of Johnson & Johnson recalled one lot, or 34,056 bottles, of Tylenol 8-Hour Extended Release caplets due to a musty odor.

Also in 2010, manufacturing defects led to the recall of 43 child and infant liquid formulations of Tylenol, Motrin, Zyrtec and Benadryl by McNeil, a division of Johnson & Johnson.

Anyone who has purchased the product with lot number ABA619, and the UPC code 300450444271, should stop using it and contact the company via it’s website at http://www.mcneilproductrecall.com, or call 888-222-6036.